Rigel Pharma (RIGL) Tops Q4 EPS by 80c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $41.94 +1.85%
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
SFNC, CSBR, MAN, More
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
SFNC, CSBR, MAN, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q4 EPS of $0.80. Revenue for the quarter came in at $57.6 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verizon to cut 3,000 jobs as it shifts stores to franchises
- IZM receives Nasdaq deficiency notice over missing financial filing
- AeroVironment may be in contract talks with army - Piper Sandler
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
